Dog /

Breed profile · FDA CVM July 2026 extract

Retriever - Golden adverse-event record

Adverse-event filings for Retriever - Golden (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

#5 of 510
by report volume (all breeds)
35,980
FDA CVM reports on file
3.7%
death-coded share of reports
#194 of 275
by death-coded share (≥50 reports)

How the 35,980 reports break down

By recorded gender -- every report on file for Retriever - Golden, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 3,304 2,478 1,652 826 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Retriever - Golden drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Retriever - Golden ranks #5 of 510 by total reports (35,980) and #194 of 275 by death-coded share (3.7%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#5
This breed, reports of 510
#194
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Retriever - Golden has 35,980 reports now versus 35,315 in that prior snapshot: 665 more (1.9%).

Report change
+665
Death-coded reports
+16
Death-coded share
−0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Retriever - Golden changes

Total Reports

35,980

Highest-reported breed

Deaths Reported

1,335

of 35,980 reports

Death-coded share of reports

3.7%

Below-median death-coded share

Avg Age at Report

4.6 yr

28.4 kg avg weight

Breed Safety Scorecard

C (57/100)

A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate B
3.7%

Share of reports coded as a fatality

Euthanasia rate C+
1.9%

Share of reports resulting in euthanasia

Full recovery rate C-
28.6%

Share of reports coded "Recovered/Normal"

5-year trend F
+27%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Retriever - Golden death-coded reports 3.7%
Cross-breed median

3.7% of 35,980 retriever - golden reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Retriever - Golden's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

4% 29th percentile Higher share than 29% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Retriever - Golden 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Retriever - Golden among report-volume vs. death-rate peers

Every breed shown has at least 50 filed reports. Volume reflects how often a breed is reported, not how common it is; death rate is the share of a breed's own reports coded as a death outcome.

Source: FDA openFDA Animal & Veterinary Adverse Events database 2×2 strategic matrix plotting 30 entities by Total Reports (X) and Death Rate (%) (Y), with a crosshair dividing the plot into four quadrants. High volume, high death rateLow volume, high death rateHigh volume, low death rateLow volume, low death rate 020,00040,00060,00080,000100,000 0%5%10%15% Total Reports Death Rate (%) Retriever - Golden vs. all breeds, report volume and death-coded share Retriever - Labrador-93675, 3.7%Crossbred Canine/dog-70591, 3.2%Domestic Shorthair-65226, 7.2%Dog (unknown)-48820, 8.8%Retriever - Golden-35980, 3.7%Shepherd Dog - German-32220, 4.4%Chihuahua-31521, 4.2%Terrier - Yorkshire-24924, 3.7%Shih Tzu-24405, 3.6%Boxer (German Boxer)-19405, 4.4%Beagle-17970, 3.6%Pit Bull-17865, 3.1%Shepherd Dog - Australian-16274, 3.7%Terrier (unspecified)-14058, 3.1%Maltese-13940, 3.2%Dachshund (unspecified)-13512, 4.6%Cat (unknown)-13248, 9.3%Terrier - Jack Russell-10423, 3.7%Collie - Border-10130, 4.3%Siberian Husky-9811, 4.5%Domestic Longhair-9615, 7%Pug-9224, 5.2%Spitz - German Pomeranian-9086, 4.9%Terrier - Bull - American Pit-8769, 4.7%Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog)-7871, 3.6%Terrier - Boston-7737, 4.5%Spaniel - Cocker American-7640, 4%Domestic (unspecified)-7576, 13.4%Poodle (unspecified)-7534, 3.4%Schnauzer - Miniature-7513, 4.4%
Source: FDA openFDA Animal & Veterinary Adverse Events database
Average weight at time of report: 28.4 kg (62.6 lbs)

Top Reported Reactions

Vomiting 6,763
Lack of efficacy (endoparasite) - hookworm 3,119
Diarrhoea 3,044
Lethargy (see also Central nervous system depression in 'Neurological') 2,729
Emesis 2,017
Lack of efficacy - NOS 1,722
Digestive tract disorder NOS 1,646
Seizure NOS 1,642
Lack of efficacy (endoparasite) - roundworm NOS 1,365
Lack of efficacy (endoparasite) - heartworm 1,326
Lack of efficacy (bacteria) - Borrelia 1,292
Lack of efficacy (ectoparasite) - tick NOS 1,269
INEFFECTIVE, HEARTWORM LARVAE 1,262
Lack of efficacy (ectoparasite) - flea 1,170
INEFFECTIVE, ASCARIDS NOS 1,082

Most Referenced Drugs

Milbemycin Oxime + Spinosad 5,544
Ivermectin + Pyrantel As Pamoate Salt 4,714
Pyrantel Pamoate;Sarolaner 4,305
Afoxolaner 3,405
Milbemycin Oxime + Praziquantel 2,025
Moxidectin 1,613
Oclacitinib Maleate 1,352
Carprofen 1,148
Fluralaner 13.64% 12-Week Chew 1,053
Bedinvetmab 1,020
Fluralaner Chew Tablets 1,006
Spinosad 962
Sarolaner 929
Lotilaner 769
Ivermectin/Pyrantel Pamoate Chewable 272Mcg/652Mg 538

Outcome Breakdown

Outcome Unknown
11,522 (33.8%)
Recovered/Normal
10,302 (30.2%)
Ongoing
10,083 (29.5%)
Recovered with Sequela
897 (2.6%)
Euthanized
679 (2.0%)
Died
656 (1.9%)

Gender Distribution

Male 18,178 (50.5%)
Female 17,104 (47.5%)
Unknown 614 (1.7%)
Mixed 84 (0.2%)

Reports by Year

Year Reports Trend
2010 1,016
2011 1,117
2012 1,686
2013 1,899
2014 1,931
2015 2,131
2016 2,232
2017 2,476
2018 2,245
2019 2,379
2020 2,324
2021 2,393
2022 2,500
2023 2,795
2024 3,304
2025 3,045
2026 507

Retriever - Golden: low death-coded share in the FDA CVM extract

Signature read: 35,980 reports place Retriever - Golden in the upper third of breed filing volume (#5 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Retriever - Golden sits at #5 of 510 by report volume among all breeds and #4 of 298 among dog breeds, with 35,980 reports and 1,335 (3.7%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #194 of 275. Mean age at report: 4.6 years, average weight 28.4 kg (62.6 lbs).

Top reported signs: Vomiting (6,763), Lack of efficacy (endoparasite) - hookworm (3,119), Diarrhoea (3,044). Most-referenced drug: Milbemycin Oxime + Spinosad (5,544 reports), followed by Ivermectin + Pyrantel As Pamoate Salt (4,714) and Pyrantel Pamoate;Sarolaner (4,305).

Outcome coding on 34,139 status-recorded reports is dominated by Outcome Unknown (33.8%). Annual submissions ranged 507-2,026 across 17 years on file.

Retriever - Golden Reporting Concentration Profile

Retriever - Golden is a high-volume FDA CVM cohort (35,980 reports) - enough filings to measure how concentrated the reaction and drug mix is, not just the headline totals. Across 20 named reaction terms in the stored top list, the leading three (Vomiting, Lack of efficacy (endoparasite) - hookworm, Diarrhoea) account for 36.2% of listed reaction mentions. The Herfindahl index on that list is 0.078 (1.0 = a single reaction owns every mention; lower = a broader clinical mix).

On the drug side, 20 referenced products appear in the top list; the leading three (Milbemycin Oxime + Spinosad, Ivermectin + Pyrantel As Pamoate Salt, Pyrantel Pamoate;Sarolaner) cover 44.7% of those mentions. That multi-product footprint is the profile thin-report breeds cannot show - their pages stop at a short bar list because the sample cannot support a concentration read.

Outcome coding on 34,139 status-recorded filings splits roughly 3.9% severe (died or euthanized - 1,335 reports) versus 32.8% recovered or recovered-with-sequela (11,199). Read that split next to the 3.7% death-coded share above - both track reporting severity bias in a popular breed, not a proven mortality rate.

Peak filing year was 2024 (3,304 reports); the lightest year on file was 2026 (507). From 2024 to 2025, annual volume fell 7.8% (3,304 → 3,045). Year-to-year swings at this volume usually track product launches, owner awareness, and reporting campaigns more than sudden breed-health shocks.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

High-volume peer sets for Retriever - Golden drawn from openFDA outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (3.7% death-coded here).

Similar average weight

Nearest other-species breeds by reported average weight (28.4 kg here).

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Retriever - Golden?
There are 35,980 adverse event reports involving Retriever - Golden in the FDA database, of which 1,335 were death-coded (3.7% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Retriever - Golden ranks #5 of 510 by report volume among all breeds PlainBreed indexes (#4 of 298 among dog breeds).
Where does Retriever - Golden sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Retriever - Golden is #5 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #4 of 298. Among breeds with at least 50 reports, its death-coded share ranks #194 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Retriever - Golden?
The most commonly reported adverse reactions for Retriever - Golden are Vomiting (6,763 reports), Lack of efficacy (endoparasite) - hookworm (3,119 reports), Diarrhoea (3,044 reports), Lethargy (see also Central nervous system depression in 'Neurological') (2,729 reports), Emesis (2,017 reports).
What drugs are most frequently associated with Retriever - Golden adverse events?
The drugs most frequently referenced in Retriever - Golden adverse event reports are Milbemycin Oxime + Spinosad (5,544 reports), Ivermectin + Pyrantel As Pamoate Salt (4,714 reports), Pyrantel Pamoate;Sarolaner (4,305 reports), Afoxolaner (3,405 reports), Milbemycin Oxime + Praziquantel (2,025 reports).
What is the average age of Retriever - Golden in adverse event reports?
The average age of Retriever - Golden at the time of adverse event reports is 4.6 years, with an average weight of 28.4 kg (62.6 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Retriever - Golden (Dog), extract as of July 2026 extract. 35,980 reports · 1,335 death-coded (3.7% of reports, not a mortality rate) · #5 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →